Related Experiment Videos
Tetracycline does not affect the trauma- and leukotriene B4-induced intraepidermal accumulation of polymorphonuclear
A Chang1, P Steegmans, P C van de Kerkhof
1Department of Dermatology, University Hospital, Nijmegen, The Netherlands.
Abstract:
The transepidermal migration of polymorphonuclear leukocytes is a well established target for antipsoriatic therapies. Tetracycline, although inhibiting the movement of PMN, is not an effective treatment for psoriasis. In contrast to the inhibition of PMN chemotactic response to serum and bacterial products, the leukotriene B4-induced and trauma-induced intraepidermal accumulation of PMN was unaffected by tetracycline.
Insights
Tetracycline inhibits polymorphonuclear leukocyte (PMN) migration but is ineffective for psoriasis treatment. It blocks PMN response to some stimuli but not to leukotriene B4 or trauma.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Polymorphonuclear leukocyte (PMN) transepidermal migration is a key target for psoriasis therapies.
- Tetracycline is known to inhibit PMN movement.
Purpose of the Study:
- To investigate the efficacy of tetracycline as an antipsoriatic therapy.
- To determine the specific effects of tetracycline on PMN migration in response to various stimuli.
Main Methods:
- Evaluating tetracycline's effect on PMN chemotaxis.
- Assessing PMN accumulation in response to leukotriene B4 and trauma.
Main Results:
- Tetracycline inhibited PMN chemotactic response to serum and bacterial products.
- Tetracycline did not affect PMN accumulation induced by leukotriene B4 or trauma.
Conclusions:
- Tetracycline's inhibition of PMN migration is specific and does not translate to broad efficacy in psoriasis.
- The findings suggest limitations of targeting PMN migration with tetracycline for psoriasis treatment.